Skip to main content
    T

    Teladoc Inc (TDOC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $8.80
    +0.11 (+1.27%)

    Market Cap: $1.60B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Teladoc Inc (TDOC) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Teladoc (TDOC) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, Teladoc reported EPS of -$0.15, above the -$0.23 estimate. It beat the EPS estimate in each of the last 15 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    76%(29/38)
    Avg Surprise
    +11.56%
    Streak
    20 Q

    Upcoming Estimates

    Reports Feb 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.11
    Range-$0.19 - -$0.03
    23 analysts
    Revenue Consensus
    $608.33M
    Range$570.65M - $643.23M
    23 analysts
    Reports Apr 27, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.17
    Range-$0.20 - -$0.14
    2 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.23+24.4%
    60d ago-$0.23+24.4%
    30d ago-$0.23+24.4%
    7d ago-$0.19+10.5%
    Current-$0.17
    Revenue Consensus
    $587.87M
    Range$572.80M - $614.79M
    13 analysts

    Next Report

    TDOC has an expected report date of Feb 23, 2027.

    TDOC Earnings Call

    The latest TDOC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 38 quarters below that had an estimate, TDOC beat 29, missed 8 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $605.10M, down 3.4% from $626.44M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.15-$0.23-$0.23 - -$0.15+34.78%BeatN/A30 up, 2 downOct 28, 2026$605.10M
    Jun 30, 2026-$0.21-$0.24-$0.24 - -$0.19+12.50%BeatN/A40 up, 2 downJul 29, 2026$606.93M
    Mar 31, 2026-$0.28-$0.39-$0.40 - -$0.36+28.21%BeatN/A30 up, 2 downApr 29, 2026$613.85M
    Dec 31, 2025-$0.10-$0.18-$0.25 - -$0.17+42.97%BeatN/A52 up, 1 downFeb 25, 2026$642.27M
    Sep 30, 2025-$0.19-$0.31-$0.34 - -$0.24+38.71%BeatN/A40 up, 1 downOct 29, 2025$626.44M
    Jun 30, 2025-$0.15-$0.31-$0.36 - -$0.25+51.61%BeatN/A50 up, 2 downJul 29, 2025$631.90M
    Mar 31, 2025-$0.22-$0.36-$0.42 - -$0.30+38.89%BeatN/A52 up, 1 downApr 30, 2025$629.37M
    Dec 31, 2024-$0.25-$0.29-$0.36 - -$0.22+16.43%BeatN/A30 up, 1 downFeb 26, 2025$640.49M
    Sep 30, 2024-$0.17-$0.32-$0.37 - -$0.13+46.88%BeatN/A210 up, 0 downOct 30, 2024$640.51M
    Jun 30, 2024-$0.27-$0.37-$0.41 - -$0.18+27.03%BeatN/A200 up, 2 downJul 31, 2024$642.44M
    Mar 31, 2024-$0.43-$0.44-$0.54 - -$0.28+2.27%BeatN/A210 up, 0 downApr 25, 2024$646.13M
    Dec 31, 2023-$0.17-$0.21-$0.32 - $0.16+19.05%BeatN/A191 up, 0 downFeb 20, 2024$660.53M
    Sep 30, 2023-$0.31-$0.37-$0.46 - -$0.27+16.22%BeatN/A200 up, 0 downOct 24, 2023$660.24M
    Jun 30, 2023-$0.32-$0.42-$0.50 - -$0.22+23.81%BeatN/A212 up, 0 downJul 25, 2023$652.41M
    Mar 31, 2023-$0.34-$0.49-$0.64 - -$0.30+30.61%BeatN/A190 up, 1 downApr 26, 2023$629.24M
    Dec 31, 2022-$23.49-$0.25-$0.65 - -$0.09N/AN/AN/A211 up, 0 downFeb 22, 2023$637.71M
    Sep 30, 2022-$0.42-$0.49-$0.77 - -$0.13+14.29%BeatN/A230 up, 0 downOct 26, 2022$611.40M
    Jun 30, 2022-$0.43-$0.59-$1.13 - -$0.52+27.12%BeatN/A180 up, 0 downJul 27, 2022$592.38M
    Mar 31, 2022-$0.44-$0.53-$0.70 - -$0.45+16.98%BeatN/A202 up, 1 downApr 27, 2022$565.35M
    Dec 31, 2021-$0.07-$0.56-$0.91 - -$0.20+87.50%BeatN/A19N/AFeb 22, 2022$554.24M
    Sep 30, 2021-$0.50-$0.62-$0.81 - -$0.22+19.35%BeatN/A20N/AOct 27, 2021$521.66M
    Jun 30, 2021-$0.58-$0.54-$1.30 - -$0.17-7.41%MissN/A23N/AJul 27, 2021$503.14M
    Mar 31, 2021-$1.24-$0.57-$0.92 - -$0.17-117.54%MissN/A19N/AApr 28, 2021$453.68M
    Dec 31, 2020-$3.07-$0.24-$0.48 - -$0.12N/AN/AN/A16N/AFeb 24, 2021$383.32M
    Sep 30, 2020-$0.43-$0.31-$0.39 - -$0.25-38.71%MissN/A23N/AOct 28, 2020$288.81M
    Jun 30, 2020-$0.34-$0.24-$0.28 - -$0.09-41.67%MissN/A24N/AJul 29, 2020$241.03M
    Mar 31, 2020-$0.40-$0.36-$0.40 - -$0.31-11.11%MissN/A20N/AApr 29, 2020$180.80M
    Dec 31, 2019-$0.26-$0.32-$0.40 - -$0.29+18.75%BeatN/A19N/AFeb 26, 2020$156.49M
    Sep 30, 2019-$0.28-$0.39-$0.43 - -$0.28+28.21%BeatN/A19N/AOct 30, 2019$137.97M
    Jun 30, 2019-$0.41-$0.41-$0.43 - -$0.330.00%In lineN/A18N/AJul 31, 2019$130.28M
    Mar 31, 2019-$0.43-$0.44-$0.53 - -$0.35+2.27%BeatN/A17N/AApr 30, 2019$128.57M
    Dec 31, 2018-$0.35-$0.36-$0.40 - -$0.22+2.78%BeatN/A16N/AFeb 27, 2019$122.74M
    Sep 30, 2018-$0.34-$0.36-$0.41 - -$0.33+5.56%BeatN/A16N/ANov 1, 2018$110.96M
    Jun 30, 2018-$0.37-$0.36-$0.49 - -$0.31-2.78%MissN/A13N/AAug 1, 2018$94.56M
    Mar 31, 2018-$0.36-$0.42-$0.45 - -$0.38+14.29%BeatN/A15N/AMay 1, 2018$89.64M
    Dec 31, 2017-$0.76-$0.49-$0.68 - -$0.31-55.10%MissN/A14N/AFeb 27, 2018$77.14M
    Sep 30, 2017-$0.38-$0.51-$0.68 - -$0.22+25.49%BeatN/A13N/ANov 1, 2017$68.65M
    Jun 30, 2017-$0.28-$0.26-$0.27 - -$0.23-7.69%MissN/A13N/AAug 2, 2017$44.59M
    Mar 31, 2017-$0.30-$0.34N/A+11.76%BeatN/AN/AN/AMay 8, 2017$42.90M
    Dec 31, 2016-$0.29-$0.35N/A+17.14%BeatN/AN/AN/AMar 1, 2017$37.40M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.66, after -$1.12 the year before. It was -$1.40 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.66N/A
    Dec 31, 2024-$1.12N/A
    Dec 31, 2023-$1.14N/A
    Dec 31, 2022-$24.78N/A
    Dec 31, 2021-$2.39N/A
    Dec 31, 2020-$4.24N/A
    Dec 31, 2019-$1.38N/A
    Dec 31, 2018-$1.42N/A
    Dec 31, 2017-$1.72N/A
    Dec 31, 2016-$1.40N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 15 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,16615
    2026Q2Jun 30, 20267,02912
    2026Q1Mar 31, 20267,48119
    2025Q4Dec 31, 20258,03717
    2025Q3Sep 30, 20256,89915
    2025Q2Jun 30, 20257,69213
    2025Q1Mar 31, 20258,60610
    2024Q4Dec 31, 20248,70114

    2026Q3 Earnings Call

    Opening remarks

    Michael Minchak Investor Relations Thank you, and good afternoon. Today, after the market close, we issued a press release announcing our third-quarter 2026 financial results. This press release and the accompanying slide presentation are available in the Investor Relations section of the teladochealth.com website. On this call to discuss the results will be Charles Divita, Chief Executive Officer, and Mike Grasher, Chief Financial Officer. During this call, we will also discuss our outlook. Our prepared remarks will be followed by a question-and-answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating our performance. Details on the relationship between these non-GAAP measures and the most comparable GAAP measures, and reconciliations thereof, can be found in the press release posted on our website. During this call, we will make forward-looking statements as defined by the Private Securities Litigation Reform Act of 2000. Examples of forward-looking statements include, without limitation, statements regarding our financial and operational outlook; the timing, availability, market response, and performance of new products, including Teladoc 1; expected BetterHelp insurance revenue and exit run rate; expected cash-pay trends; provider network capacity; advertising and marketing spending and efficiency; the timing and impact of our BetterHelp insurance rollout; and the expected benefits of the actions we are taking. Such statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to the cautionary statement in today's earnings release and the risk factors in our most recent Form 10-K and Form 10-Q, including risks relating specifically to each of our reporting segments. I would now like to turn the call over to Chuck.

    Charles Divita CEO Thanks, Mike. This quarter reflected solid execution across the business and underlying traction on initiatives supporting our strategic priorities. There is more work ahead, but we are encouraged by the progress made in the quarter. Before I get started, I would like to welcome Mike Grasher, our new Chief Financial Officer, to the call. Mike joined in late August and brings over 12 years of CFO experience at both publicly traded and privately held companies. We are excited to have him on board. You will hear from Mike in a moment when he covers our third-quarter results in more detail and our outlook. As we look at the business today, we remain highly focused on advancing the priorities we believe are most important to the long-term success of the company. With respect to the third-quarter results, consolidated revenue came in near the upper end of our guidance range, and adjusted EBITDA was above guidance, with both segments contributing to the quarter's performance.

    Frequently Asked Questions About TDOC

    When is Teladoc's next earnings date?

    Teladoc's next earnings report is expected for Feb 23, 2027.

    Did TDOC beat earnings estimates last quarter?

    Yes. Teladoc reported EPS of -$0.15 for the quarter ended Sep 30, 2026, above the -$0.23 estimate, a 34.78% surprise.

    What EPS do analysts expect from TDOC next quarter?

    The consensus EPS estimate for Teladoc for the quarter ending Dec 31, 2026 is -$0.11 from 23 analysts, with estimates from -$0.19 to -$0.03.

    How often does TDOC beat earnings estimates?

    Teladoc beat the EPS estimate in each of the last 15 quarters, with an average surprise of +28.66%.